Foghorn Therapeutics Inc.
NASDAQ:FHTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Foghorn Therapeutics Inc.
NASDAQ:FHTX
|
US |
|
C
|
Canal+ SA
LSE:CAN
|
FR |
|
N
|
Nine Dragons Paper (Holdings) Ltd
XMUN:N3Y
|
HK |
|
PagSeguro Digital Ltd
NYSE:PAGS
|
BR |
|
E
|
EBR Systems Inc
ASX:EBR
|
US |
|
Guangdong Songfa Ceramics Co Ltd
SSE:603268
|
CN |
|
M
|
Mincon Group PLC
ISEQ:MIO
|
IE |
|
Grab Holdings Ltd
NASDAQ:GRAB
|
SG |
|
Tokyo Century Corp
TSE:8439
|
JP |
|
Plug Power Inc
NASDAQ:PLUG
|
US |
|
Adyen NV
AEX:ADYEN
|
NL |
|
Adobe Inc
NASDAQ:ADBE
|
US |
Bankruptcy Probability
Foghorn Therapeutics Inc.'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Foghorn Therapeutics Inc. Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Foghorn Therapeutics Inc.
NASDAQ:FHTX
|
204m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
377.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Foghorn Therapeutics Inc.'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Foghorn Therapeutics Inc. has no debt.
You can find a full breakdown on its Balance Sheet.
